MARKET

SNPX

SNPX

Synaptogenix
NASDAQ
0.1875
-0.0030
-1.57%
After Hours: 0.1880 +0.0005 +0.27% 17:45 03/28 EDT
OPEN
0.1990
PREV CLOSE
0.1905
HIGH
0.2050
LOW
0.1875
VOLUME
123.37K
TURNOVER
0
52 WEEK HIGH
1.880
52 WEEK LOW
0.1411
MARKET CAP
3.82M
P/E (TTM)
-0.1757
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at SNPX last week (0318-0322)?
Weekly Report · 3d ago
Weekly Report: what happened at SNPX last week (0311-0315)?
Weekly Report · 03/18 11:21
12 Health Care Stocks Moving In Thursday's After-Market Session
Geron stock increased by 90.8% to $3.34 during Thursday's after-market session. Madrigal Pharmaceuticals (NASDAQ:MDGL) stock rose 23.16% to $300.0. DIH Holding US shares rose 10.37% during the after- market session.
Benzinga · 03/14 21:33
Weekly Report: what happened at SNPX last week (0304-0308)?
Weekly Report · 03/11 11:18
Weekly Report: what happened at SNPX last week (0226-0301)?
Weekly Report · 03/04 11:21
Weekly Report: what happened at SNPX last week (0219-0223)?
Weekly Report · 02/26 11:35
Why Etsy Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Shares of Etsy, Inc. Fell 7.5% to $71.34 on Thursday. The company reported mixed fourth-quarter financial results. La Rosa Holdings Corp. Shares jumped 160.7% after the company announced the sale of a stake in BuzzFeed. Novavax, Inc., and Root were among the other stocks moving in the mid-day session.
Benzinga · 02/22 18:37
12 Health Care Stocks Moving In Thursday's Intraday Session
Monopar Therapeutics shares increased by 85.9% to $1.06 during Thursday's regular session. Ocular Therapeutix stock rose 30.11%. Novavax shares rose 24.62%. Q4 earnings report came out yesterday. Losers Synaptogenix (NASDAQ:SNPX) and BioSig Technologies.
Benzinga · 02/22 17:31
More
About SNPX
Synaptogenix, Inc. is a biopharmaceutical company. The Company is principally focused on developing therapeutics for patients with neurodegenerative diseases and developmental disorders. The Company is focused on developing a product platform based on a drug candidate called Bryostatin-1, which is synthesized from a natural product (bryostatin) that is isolated from a marine invertebrate organism, for the treatment of Alzheimer's disease (AD). Bryostatin-1 is a Protein Kinase C Epsilon (PKC e), a and e activator that was originally developed as a potential anticancer drug. The Company is evaluating therapeutic applications of bryostatin for other neurodegenerative or cognitive diseases and dysfunctions, such as Fragile X syndrome, Multiple Sclerosis (MS), and Niemann-Pick Type C disease.

Webull offers Synaptogenix Inc stock information, including NASDAQ: SNPX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SNPX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SNPX stock methods without spending real money on the virtual paper trading platform.